超级耐火状态症在加纳克索隆紧急使用后得到改善:案例报告
Jody Manners1,2, Emily Jusuf1, Gunjan Y Parikh1
1Department of Neurology, Program in Trauma, University of Maryland School of Medicine, Baltimore, MD, USA.
The Neurohospitalist
|June 19, 2024
概括
一名患有COVID-19肺炎的超级耐火状态的患者表现出静脉注射ganaxolone的持续改善. 这种神经活性类固醇向GABAA受体,为耐火性病例提供了一种新的治疗方法.
科学领域:
- 神经学 神经学
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
背景情况:
- 超耐火状态 (SRSE) 是一种罕见但严重的神经紧急情况.
- COVID-19肺炎与各种神经系统并发症有关,包括发作.
- 现有的SRSE治疗方法通常具有有限的疗效和显著的副作用.
研究的目的:
- 在患有COVID-19肺炎的患者中报告SRSE病例.
- 为了评估静脉注射加纳克索隆在耐火性患者的疗效.
- 在重症监护环境中描述 ganaxolone 的新型剂量范式.
主要方法:
- 一名患有和COVID-19肺炎的34岁男性患者患上了SRSE.
- 积极的常规疗法 (亲肠道,肠道,非药物治疗) 没有取得成功.
- 对静脉注射的GABAA受体调节器 ganaxolone获得紧急使用授权.
主要成果:
- 患者经历了重复的电图状态,尽管最大的治疗.
- 在静脉注射 ganaxolone 后,观察到持续的临床和电图改善.
- 新的 ganaxolone 剂量模式已成功实施.
结论:
- 静脉注射甘可能是超耐火状态的有效治疗选择,特别是在COVID-19等严重感染的背景下.
- 向GABAA受体的 ganaxolone 提供了一个有前途的治疗策略,用于耐火性.
- 进一步的研究是有必要的,以探索 ganaxolone 在管理状态和其他严重的神经疾病的作用.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
169
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
169
Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
Antiepileptic Drugs: Glutamate Antagonists
319
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
319
Parenteral Anesthetics: Overview
118
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
118
Depolarizing Blockers: Pharmocokinetics
318
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
318


